First, let me begin by saying I am not an idiot.  I clearly recognize that ADHD is a certified medical condition as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association (DSM 5).  In addition, I recognize that the symptoms described in the DSM-5 are very real:  things like ‘’fidgets’’ ‘’blurts out...Read More

A recent study that has appeared in the journal NeuroImage:Clinical, reports that subjects who had been treated with methylphenidate (Ritalin) before the age of 16, had significantly lower levels of the inhibitory neurotransmitter gamma-Aminobutyric acid (GABA) as adults, compared with subjects who had started methylphenidate therapy after age 23, and subjects who had never taken psychostimulants....Read More

Over the next month, 55+ million children and adolescents will be returning to their classrooms in public and private schools around the country. Out of this number, 6.4 million students have been diagnosed as having ADHD and most of them take psychostimulants or other drugs to control their symptoms. And while parents scurry around anxiously...Read More

The following article is based on my book The Myth of the ADHD Child: 101 Ways to Improve Your Child’s Behavior and Attention Span Without Drugs, Labels, or Coercion.  It was originally posted on my publisher’s (Tarcher-Pereigee) website: ”Learn, Create, Grow,” on August 31, 2017. FACT: ADHD is a disorder characterized by hyperactivity, impulsivity, and...Read More

I read an online article today from Benzinga, a financial media company that empowers its readers with daily actionable market analysis and commentary.  It reported on a new ADHD drug that the FDA had just approved, called Cotempla XR-OTD, a methylphenidate extended release orally-disintegrating tablet for treating ADHD in kids aged 6-17.  According to BMO...Read More